Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

13.34
+0.13000.98%
Post-market: 13.33-0.0100-0.07%19:59 EDT
Volume:7.45M
Turnover:98.70M
Market Cap:2.69B
PE:-62.83
High:13.67
Open:13.33
Low:12.94
Close:13.21
52wk High:15.88
52wk Low:1.39
Shares:201.95M
Float Shares:199.00M
Volume Ratio:0.85
T/O Rate:3.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2123
EPS(LYR):-0.2463
ROE:-39.63%
ROA:-23.30%
PB:19.57
PE(LYR):-54.15

Loading ...

Sellas Life Sciences files automatic mixed securities shelf

TIPRANKS
·
Mar 21

Sellas Life Sciences Group Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 21

Sellas Life Sciences price target raised to $10 from $7.50 at Alliance Global

TIPRANKS
·
Mar 20

Sellas Life Sciences Group Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 20

SELLAS Life Sciences Gr Q4 EPS $(0.05) Beats $(0.07) Estimate

Benzinga Earnings
·
Mar 20

SELLAS Life Sciences 2025 net loss narrows, cash position strengthens

Reuters
·
Mar 20

BRIEF-SELLAS Life Sciences FY Net Income USD -26.863 Million

Reuters
·
Mar 20

Sellas Life Sciences FY Operating Income USD -28.274 Million

THOMSON REUTERS
·
Mar 20

Press Release: SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 20

Sellas Life Sciences FY 2025 net loss narrowed 13% to USD 26.86 million

Reuters
·
Mar 20

Sellas Life Sciences options imply 6.2% move in share price post-earnings

TIPRANKS
·
Mar 20

Canaccord Genuity Reaffirms Their Buy Rating on Solstice Minerals Limited (SLS)

TIPRANKS
·
Mar 19

Sims Scores Upbeat Fiscal 2026 Guidance on Americas JV Strength

MT Newswires Live
·
Mar 19

Guess which ASX 200 stock is jumping 17% on strong FY26 guidance

MotleyFool
·
Mar 18

Sellas Life Sciences to present preclinical SLS009 data at AACR conference

TIPRANKS
·
Mar 18

SELLAS Life Sciences to present SLS009 AML preclinical data at AACR poster session

Reuters
·
Mar 18

Sellas Life Sciences Group Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
Mar 16

SELLAS (SLS): Advancing AML Pipeline, Strengthened Balance Sheet, and Upcoming Catalysts Drive Higher Target and Buy Rating

TIPRANKS
·
Mar 14

Sellas Life Sciences enrolls first patient in 80-patient Phase 2 SLS009 first-line AML trial

Reuters
·
Mar 12

Sellas Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line Aml Trial of Sls009

THOMSON REUTERS
·
Mar 12